Stem Cells News
-
Stem Cells | News | 0 Comment | 22 Jul, 2024
Japan-headquartered Astellas Pharma Inc. and Graduate School of Medicine / Faculty of Medicine, Osaka University ha...Read more
-
Japan's Healios inks stem cells production deal with Astellas Pharma for $8 M
Stem Cells | News | 0 Comment | 21 Jun, 2024
Japan-based Healios K.K. has entered into a license agreement with Astellas Institute for Regenerative Medicine (A...Read more
-
Stem Cells | News | 0 Comment | 21 Mar, 2024
US-based Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yon...Read more
-
Stem Cells | News | 0 Comment | 07 Mar, 2024
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...Read more
-
Andelyn Biosciences to Produce Gene Therapies for Rare Diseases
Stem Cells | News | 0 Comment | 29 Feb, 2024
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing...Read more
-
AstraZeneca expands US manufacturing footprint to accelerate next-gen cell therapy development
Stem Cells | News | 0 Comment | 07 Feb, 2024
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...Read more
-
Japan takes major step forward in advancing autologous cardiac regenerative medicine
Stem Cells | News | 0 Comment | 02 Nov, 2023
I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies based in Palo Alto...Read more
-
ACTRIS unveils its new cell therapy facility to boost Singapore’s cell and gene therapy capabilities
Stem Cells | Company results | By Hithaishi C Bhaskar | 2 Comment | 04 Aug, 2023
The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) launched a new 2,000 sqm cell therapy facility...Read more
-
Hong Kong advances stem cell therapy, improves awareness of regenerative medicine
Stem Cells | News | 0 Comment | 24 Jul, 2023
Hong Kong Science and Technology Parks Corporation (HKSTP) partner companies Hong Kong Regen MedTech Limited (HKRM) and ...Read more
-
Stem Cells | Opinion | By Hithaishi C Bhaksar | 0 Comment | 03 Jul, 2023
China-based CytoNiche Biotechnology, a pioneer in 3D dissolvable porous microcarriers, has opened the Center of Excellen...Read more
-
Understanding Single-Cell Technology in clinical research applications
Stem Cells | Analysis | 1 Comment | 21 Apr, 2023
Single-cell analysis technology has contributed significantly to medical research. In the past few years, single-cell RN...Read more
-
Singapore-Sweden research reveals promising stem cell approach for restoring vision in blindness
Stem Cells | News | 0 Comment | 17 Apr, 2023
A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the ...Read more
-
Korea designs Myocardial Infarction treatment patch
Stem Cells | News | 0 Comment | 19 Dec, 2022
Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic ...Read more
-
Australia invests $7M in country's first stem cell research
Stem Cells | News | 0 Comment | 13 Oct, 2022
The Albanese Government is investing almost $7 million in Australia first stem cell research that will enable live stem ...Read more
-
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
Stem Cells | News | 0 Comment | 28 Sep, 2022
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more
-
Australia develops new solution for stem cell manufacturing
Stem Cells | News | 0 Comment | 23 Jun, 2022
Researchers at University of Technology Sydney have developed a unique 3D printed system for harvesting stem cells from ...Read more
-
CellOrigin raises new funds to Jump-start iPSC immune cell therapy products toward clinics
Stem Cells | News | 0 Comment | 30 Mar, 2022
China's CellOrigin Inc, a biotech company focusing on iPSC-derived immune cell therapies, announced it secured a new rou...Read more
-
"Stem cell-based therapeutics poised to become mainstream option”
Stem Cells | Opinion | By Hithaishi C Bhaksar | 3 Comment | 01 Oct, 2021
To make the trial investments more meaningful and to avoid ambivalence in animal models, medical science is adopting nov...Read more
